Literature DB >> 28663447

Cholera vaccine faces major test in Yemen.

Kai Kupferschmidt.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28663447     DOI： 10.1126/science.356.6345.1316

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  3 in total

1.  Transmission dynamics of cholera in Yemen, 2017: a real time forecasting.

Authors:  Hiroshi Nishiura; Shinya Tsuzuki; Baoyin Yuan; Takayuki Yamaguchi; Yusuke Asai
Journal:  Theor Biol Med Model       Date:  2017-07-26       Impact factor: 2.432

Review 2.  Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis.

Authors:  Qifang Bi; Eva Ferreras; Lorenzo Pezzoli; Dominique Legros; Louise C Ivers; Kashmira Date; Firdausi Qadri; Laura Digilio; David A Sack; Mohammad Ali; Justin Lessler; Francisco J Luquero; Andrew S Azman
Journal:  Lancet Infect Dis       Date:  2017-07-17       Impact factor: 25.071

3.  A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol®, a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines.

Authors:  Paola Russo; Antonio D Ligsay; Remigio Olveda; Seuk Keun Choi; Deok Ryun Kim; Ju Yeon Park; Ju Yeong Park; Khalid Ali Syed; Ayan Dey; Yang Hee Kim; Sung Hee Lee; Jayoung Kim; Yun Chon; Laura Digilio; Chan Wha Kim; Jean-Louis Excler
Journal:  Vaccine       Date:  2018-06-09       Impact factor: 3.641
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.